In the present study, CD133 and CD44, especially CD44, were upregulated in endometrial cancer cells in tumorsphere formation assay, suggesting that stemness is increased in this cancer stem cell model (Figure 3E,F). This evidence concerns the gene PROM1 and endometrial cancer.